Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06439069
BMI-Driven Tolerability and Efficacy of Entresto in Heart Failure Patients
Sponsor: Lithuanian University of Health Sciences
View on ClinicalTrials.gov
Summary
This study aims to determine if patients with higher BMI can tolerate higher doses of Entresto (sacubitril/valsartan) and experience better symptomatic and functional outcomes compared to patients with lower BMI.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
340
Start Date
2023-08-10
Completion Date
2024-12-01
Last Updated
2024-06-03
Healthy Volunteers
No
Conditions
Locations (1)
Hospital of Lithuanian University of Health Sciences Kaunas Clinics
Kaunas, Lithuania